These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8930940)

  • 1. Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide.
    degli Uberti EC; Bondanelli M; Margutti A; Ambrosio MR; Valentini A; Campo M; Franceschetti P; Zatelli MC; Pansini R; Trasforini G
    Neuroendocrinology; 1996 Nov; 64(5):398-404. PubMed ID: 8930940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human galanin reduces plasma norepinephrine levels in man.
    degli Uberti EC; Ambrosio MR; Bondanelli M; Trasforini G; Margutti A; Valentini A; Rossi R; Franceschetti P
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1894-8. PubMed ID: 7539818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man.
    degli Uberti EC; Ambrosio MR; Bondanelli M; Trasforini G; Valentini A; Rossi R; Margutti A; Campo M
    Eur J Endocrinol; 1995 Dec; 133(6):723-8. PubMed ID: 8548058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans.
    Todd JF; Edwards CM; Ghatei MA; Bloom SR
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1060-6. PubMed ID: 10827009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
    Del Rio G; Procopio M; Bondi M; Marrama P; Menozzi R; Oleandri SE; Grottoli S; Maccario M; Velardo A; Ghigo E
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1111-4. PubMed ID: 9426377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of galanin and the galanin receptor antagonist galantide on plasma catecholamine levels during a psychosocial stress stimulus in rats.
    Ceresini G; Sgoifo A; Freddi M; Musso E; Parmigiani S; Del Rio G; Valenti G
    Neuroendocrinology; 1998 Jan; 67(1):67-72. PubMed ID: 9485171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent effects of human galanin in man: growth hormone secretion and vagal blockade.
    Carey DG; Iismaa TP; Ho KY; Rajkovic IA; Kelly J; Kraegen EW; Ferguson J; Inglis AS; Shine J; Chisholm DJ
    J Clin Endocrinol Metab; 1993 Jul; 77(1):90-3. PubMed ID: 7686918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
    Ghigo E; Bellone J; Imperiale E; Arvat E; Mazza E; Valetto MR; Boffano GM; Cappa M; Loche S; De Sanctis C
    Neuroendocrinology; 1990 Jul; 52(1):42-5. PubMed ID: 1697660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
    Ahrén B; Veith RC; Paquette TL; Taborsky GJ
    Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sex on the increase of GH induced by galanin, alone or in combination with GHRH with or without pyridostigmine in pubescent subjects].
    Guzzaloni G; Grugni G; Ardizzi A; Moro D; Calò G; Morabito F
    Minerva Endocrinol; 1996 Jun; 21(2):53-7. PubMed ID: 9026681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.
    Bondanelli M; Alboni P; Margutti A; Franceschetti P; Dinelli M; Gruppillo P; Marchi P; degli Uberti EC
    Metabolism; 2003 Mar; 52(3):315-21. PubMed ID: 12647269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man.
    Cappa M; Grossi A; Benedetti S; Drago F; Loche S; Ghigo E
    J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corelease of galanin and NE from pancreatic sympathetic nerves during severe hypoglycemia in dogs.
    Havel PJ; Mundinger TO; Veith RC; Dunning BE; Taborsky GJ
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E8-16. PubMed ID: 1379000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M; Ibsen H; Worck R
    Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Loche S; Vista N; Ghigo E; Vannelli S; Arvat E; Benso L; Corda R; Cella SG; Müller EE; Pintor C
    Pediatr Res; 1990 Apr; 27(4 Pt 1):405-7. PubMed ID: 1692988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of circulating galanin levels after exercise-induced pituitary hormone secretion in man.
    Ceresini G; Marchini L; Fabbo A; Freddi M; Pasolini G; Reali N; Troglio G; Valenti G
    Metabolism; 1997 Mar; 46(3):282-6. PubMed ID: 9054470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
    Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
    Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects.
    Sant'anna ID; de Sousa EB; de Moraes AV; Loures DL; Mesquita ET; da Nóbrega AC
    Clin Sci (Lond); 2003 Aug; 105(2):161-5. PubMed ID: 12627998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.